Validation study of cancer detection system by circulating microRNA

Validation study of cancer detection system by circulating microRNA - Validation study of cancer detection system by circulating microRNA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049412

Enrollment

100

Registered

2023-01-31

Start date

2022-10-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer, biliary tract cancer, healthy control

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pancreatic/biliary cancer patient Patients diagnosed with pathologically (cytological/histological) or suspicious on the image asinvasive pancreatic duct cancer, gallbladder cancer, intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, or papillary carcinoma Patients who can collect blood within 1 monthafter registration Patients who have never undergone surgery or chemotherapy Age 20+ No active malignant disease except pancreatic/biliary tract cancer Healthy control No history or complication of malignant disease, including carcinoma in situ or intramucosalcarcinoma No history of hospitalization within the past 3months Age 50+

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
The difference in the logarithmic detection amount of each microRNA between the pancreatic/biliary cancer group and the healthy adult group.	—

Countries

Japan

Contacts

Public ContactSatoko Takizawa

Toray Industries, Inc. New Projects Development Division

satoko.takizawa.f3@mail.toray0467-32-9740

Outcome results